Gene · 8661
Papers4,269
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,269
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A widely applicable and cost-effective method for specific RNA-protein complex isolation. | Sci Rep | 2023 | 37106019 | PubTator, text mining | PubMed |
| The Timing and Magnitude of the Type I Interferon Response Are Correlated with Disease Tolerance in Arbovirus Infection. | mBio | 2023 | 37097030 | PubTator, text mining | PubMed |
| Characterization of the m6A regulator-mediated methylation modification patterns in oral squamous cell carcinoma. | Sci Rep | 2023 | 37095314 | PubTator, text mining | PubMed |
| Current progress on innate immune evasion mediated by Npro protein of pestiviruses. | Front Immunol | 2023 | 37090696 | PubTator, text mining | PubMed |
| Modeling cross-talk of RNA modification enzymes reveals tumor microenvironment-associated clinical significance and immunotherapy prediction in hepatobiliary malignancy. | MedComm (2020) | 2023 | 37090117 | PubTator, text mining | PubMed |
| O-GlcNAcylation promotes the cytosolic localization of the m6A reader YTHDF1 and colorectal cancer tumorigenesis. | J Biol Chem | 2023 | 37086786 | PubTator, text mining | PubMed |
Global quantitative proteomic analysis profiles of host protein expression in response to enterovirus A71 infection in bronchial epithelial cells based on tandem mass tag (TMT) peptide labeling coupled with LC-MS/MS uncovers the key role of proteasome in virus replication. | Virus Res | 2023 | 37072100 | PubTator, text mining | PubMed |
| Newly discovered mechanisms that mediate tumorigenesis and tumour progression: circRNA-encoded proteins. | J Cell Mol Med | 2023 | 37070530 | PubTator, text mining | PubMed |
| Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications. | Biomark Res | 2023 | 37069649 | PubTator, text mining | PubMed |
| Inter- and intratumoral proteomics and glycosaminoglycan characterization of ALK rearranged lung adenocarcinoma tissues: a pilot study. | Sci Rep | 2023 | 37069213 | PubTator, text mining | PubMed |
| Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors. | NPJ Breast Cancer | 2023 | 37069173 | PubTator, text mining | PubMed |
| The Proteins of mRNA Modification: Writers, Readers, and Erasers. | Annu Rev Biochem | 2023 | 37068770 | PubTator, text mining | PubMed |
| Novel insights into the interplay between m6A modification and programmed cell death in cancer. | Int J Biol Sci | 2023 | 37063421 | PubTator, text mining | PubMed |
| m6A-modification of cyclin D1 and c-myc IRESs in glioblastoma controls ITAF activity and resistance to mTOR inhibition. | Cancer Lett | 2023 | 37061119 | PubTator, text mining | PubMed |
| Functions of N6-methyladenosine in cancer metabolism: from mechanism to targeted therapy. | Biomark Res | 2023 | 37055798 | PubTator, text mining | PubMed |
| Identification of disease-related genes and construction of a gene co-expression database in non-alcoholic fatty liver disease. | Front Genet | 2023 | 37051599 | PubTator, text mining | PubMed |
| Nyamanini Virus Nucleoprotein and Phosphoprotein Organize Viral Inclusion Bodies That Associate with Host Biomolecular Condensates in the Nucleus. | Int J Mol Sci | 2023 | 37047525 | PubTator, text mining | PubMed |
| Specialized Ribosomes in Health and Disease. | Int J Mol Sci | 2023 | 37047306 | PubTator, text mining | PubMed |
| Novel potential drugs for the treatment of primary open-angle glaucoma using protein-protein interaction network analysis. | Genomics Inform | 2023 | 37037464 | PubTator, text mining | PubMed |
| Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m6A-modified long non-coding RNAs in lung adenocarcinoma. | Clin Epigenetics | 2023 | 37029420 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8661/papers?page=19